Mozumdar A, Liguori G: Persistent increase of prevalence of metabolic syndrome among U.S. adults: NHANES III to NHANES 1999–2006. Diabetes Care. 2011, 34 (1): 216-219. 10.2337/dc10-0879.
PubMed Central
Article
PubMed
Google Scholar
Ford ES: Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005, 28 (7): 1769-1778. 10.2337/diacare.28.7.1769.
Article
PubMed
Google Scholar
Pevet P, Challet E: Melatonin: both master clock output and internal time-giver in the circadian clocks network. J Physiology-Paris. 2011, 105 (4–6): 170-182.
Article
Google Scholar
Peschke E, Bach AG, Mühlbauer E: Parallel signaling pathways of melatonin in the pancreatic β-cell. J Pineal Res. 2006, 40 (2): 184-191. 10.1111/j.1600-079X.2005.00297.x.
CAS
Article
PubMed
Google Scholar
Ríos-Lugo MJ, Cano P, Jiménez-Ortega V, Fernández-Mateos MP, Scacchi PA, Cardinali DP, Esquifino AI: Melatonin effect on plasma adiponectin, leptin, insulin, glucose, triglycerides and cholesterol in normal and high fat–fed rats. J Pineal Res. 2010, 49 (4): 342-348. 10.1111/j.1600-079X.2010.00798.x.
Article
PubMed
Google Scholar
Nduhirabandi F, du Toit EF, Lochner A: Melatonin and the metabolic syndrome: a tool for effective therapy in obesity-associated abnormalities?. Acta Physiol. 2012, 205 (2): 209-223. 10.1111/j.1748-1716.2012.02410.x.
CAS
Article
Google Scholar
Koziróg M, Poliwczak AR, Duchnowicz P, Koter-Michalak M, Sikora J, Broncel M: Melatonin treatment improves blood pressure, lipid profile, and parameters of oxidative stress in patients with metabolic syndrome. J Pineal Res. 2011, 50 (3): 261-266. 10.1111/j.1600-079X.2010.00835.x.
Article
PubMed
Google Scholar
Bouatia-Naji N, Bonnefond A, Cavalcanti-Proenca C, Sparso T, Holmkvist J, Marchand M, Delplanque J, Lobbens S, Rocheleau G, Durand E, De Graeve F, Chèvre JC, Borch-Johnsen K, Hartikainen AL, Ruokonen A, Tichet J, Marre M, Weill J, Heude B, Tauber M, Lemaire K, Schuit F, Elliott P, Jørgensen T, Charpentier G, Hadjadj S, Cauchi S, Vaxillaire M, Sladek R, Visvikis-Siest S: A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Nat Genet. 2009, 41 (1): 89-94. 10.1038/ng.277.
CAS
Article
PubMed
Google Scholar
Prokopenko I, Langenberg C, Florez JC, Saxena R, Soranzo N, Thorleifsson G, Loos RJF, Manning AK, Jackson AU, Aulchenko Y, Potter SC, Erdos MR, Sanna S, Hottenga JJ, Wheeler E, Kaakinen M, Lyssenko V, Chen WM, Ahmadi K, Beckmann JS, Bergman RN, Bochud M, Bonnycastle LL, Buchanan TA, Cao A, Cervino A, Coin L, Collins FS, Crisponi L, de Geus EJ: Variants in MTNR1B influence fasting glucose levels. Nat Genet. 2009, 41 (1): 77-81. 10.1038/ng.290.
PubMed Central
CAS
Article
PubMed
Google Scholar
Bonnefond A, Clement N, Fawcett K, Yengo L, Vaillant E, Guillaume J-L, Dechaume A, Payne F, Roussel R, Czernichow S, Hercberg S, Hadjadj S, Balkau B, Marre M, Lantieri O, Langenberg C, Bauatia-Naji N, Charpentier G, Vaxillaire M, Rocheleau G, Wareham NJ, Sladek R, McCarthy MI, Dina C, Barroso I, Jockers R, Froguel P, Meta-Analysis of Glucose and Insulin-Related Traits Consurtium (MAGIC): Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes. Nat Genet. 2012, 44 (3): 297-301. 10.1038/ng.1053.
PubMed Central
CAS
Article
PubMed
Google Scholar
Mäntele S, Otway DT, Middleton B, Bretschneider S, Wright J, Robertson MD, Skene DJ, Johnston JD: Daily rhythms of plasma melatonin, but not plasma leptin or leptin mRNA, vary between lean, obese and type 2 diabetic men. PLoS ONE. 2012, 7 (5): e37123-10.1371/journal.pone.0037123.
PubMed Central
Article
PubMed
Google Scholar
Corbalán-Tutau D, Madrid JA, Nicolás F, Garaulet M: Daily profile in two circadian markers “melatonin and cortisol” and associations with metabolic syndrome components. Physiol Behav. 2014, 123: 231-235.
Article
PubMed
Google Scholar
McMullan CJ, Curhan GC, Schernhammer ES, Forman JP: Association of nocturnal melatonin secretion with insulin resistance in nondiabetic young women. Am J Epidemiol. 2013, 178 (2): 231-238. 10.1093/aje/kws470.
PubMed Central
Article
PubMed
Google Scholar
McMullan CJ, Schernhammer ES, Rimm EB, Hu FB, Forman JP: Melatonin secretion and the incidence of type 2 diabetes. JAMA. 2013, 309 (13): 1388-1396. 10.1001/jama.2013.2710.
PubMed Central
CAS
Article
PubMed
Google Scholar
Terry PD, Goyal A, Phillips LS, Superak HM, Kutner MH: Design and rationale of a randomized controlled trial of melatonin supplementation in men and women with the metabolic syndrome. Open Access J Clin Trials. 2013, 2013 (5): 51-59.http://dx.doi.org/10.2147/OAJCT.S39551,
Google Scholar
CONsolidated Standards of Reporting Trials (CONSORT) checklist: Downloaded from http://www.consort-statement.org. Accessed on October 13, 2013
Grundy SM, Brewer JHB, Cleeman JI, Smith JSC, Lenfant C: Definition of the metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to the definition. Circulation. 2004, 109: 433-438. 10.1161/01.CIR.0000111245.75752.C6.
Article
PubMed
Google Scholar
Lusardi P, Piazza E, Fogari R: Cardiovascular effects of melatonin in hypertensive patients well controlled by nifedipine: a 24-hour study. Br J Clin Pharmacol. 2000, 49: 423-427.
PubMed Central
CAS
Article
PubMed
Google Scholar
Buscemi N, Vandermeer B, Hooton N, Pandya R, Tjosvold L, Hartling L, Vohra S, Klassen TP, Baker G: Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis. BMJ. 2006, 332: 385-393. 10.1136/bmj.38731.532766.F6.
PubMed Central
CAS
Article
PubMed
Google Scholar
Baumgart P, Kamp J: Accuracy of the SpaceLabs Medical 90217 ambulatory blood pressure monitor. Blood Press Monit. 1998, 3: 303-307.
PubMed
Google Scholar
Altman DG: Practical Statistics for Medical Research. 1991, London: Chapman and Hall
Google Scholar
Arangino S, Cagnacci A, Angiolucci M, Vacca A, Longu G, Volpe A, Melis GB: Effects of melatonin on vascular reactivity, catecholamine levels, and blood pressure in healthy men. Am J Cardiol. 1999, 83 (9): 1417-1419. 10.1016/S0002-9149(99)00112-5.
CAS
Article
PubMed
Google Scholar
Nishiyama K, Yasue H, Moriyama Y, Tsunoda R, Ogawa H, Yoshimura M, Kugiyama K: Acute effects of melatonin administration on cardiovascular autonomic regulation in healthy men. Am Heart J. 2001, 141 (5): E1-E5.
Article
Google Scholar
Scheer FA, Van Montfrans GA, van Someren EJ, Mairuhu G, Buijs RM: Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension. Hypertension. 2004, 43 (2): 192-197. 10.1161/01.HYP.0000113293.15186.3b.
CAS
Article
PubMed
Google Scholar
Grossman E, Laudon M, Yalcin R, Zengil H, Peleg E, Sharabi Y, Kamari Y, Shen-Orr Z, Zisapel N: Melatonin reduces night blood pressure in patients with nocturnal hypertension. Am J Med. 2006, 119 (10): 898-902. 10.1016/j.amjmed.2006.02.002.
CAS
Article
PubMed
Google Scholar
Cagnacci A, Arangino S, Angiolucci M, Maschio E, Melis GB: Influences of melatonin administration on the circulation of women. Am J Physiol-Reg I. 1998, 274 (2): R335-R338.
CAS
Google Scholar
Cagnacci A, Arangino S, Angiolucci M, Melis GB, Facchinetti F, Malmusi S, Volpe A: Effect of exogenous melatonin on vascular reactivity and nitric oxide in postmenopausal women: role of hormone replacement therapy. Clin Endocrinol. 2001, 54 (2): 261-266. 10.1046/j.1365-2265.2001.01204.x.
CAS
Article
Google Scholar
Cagnacci A, Cannoletta M, Renzi A, Baldassari F, Arangino S, Volpe A: Prolonged melatonin administration decreases nocturnal blood pressure in women. Am J Hypertens. 2005, 18 (12): 1614-1618. 10.1016/j.amjhyper.2005.05.008.
CAS
Article
PubMed
Google Scholar
Lusardi P, Preti P, Savino S, Piazza E, Zoppi A, Fogari R: Effect of bedtime melatonin ingestion on blood pressure of normotensive subjects. Blood Press Monit. 1997, 2 (2): 99-
PubMed
Google Scholar
Rechcinski T, Trzos E, Wierzbowska-Drabik K, Krzeminska-Pakula M, Kurpesa M: Melatonin for nondippers with coronary artery disease: assessment of blood pressure profile and heart rate variability. Hypertens Res. 2009, 33 (1): 56-61.
Article
PubMed
Google Scholar
Pittalis S, Lissoni P, Giani L, Casati M, Kropacek N, Orfanò S, Giavolucci F, Merlini D: Effect of a chronic therapy with the pineal hormone melatonin on cholesterol levels in idiopathic hypercholesterolemic patients. Recent Progr Med. 1997, 88 (9): 401-402.
CAS
PubMed
Google Scholar
Tamura H, Nakamura Y, Narimatsu A, Yamagata Y, Takasaki A, Reiter RJ, Sugino N: Melatonin treatment in peri‒and postmenopausal women elevates serum high‒density lipoprotein cholesterol levels without influencing total cholesterol levels. J Pineal Res. 2008, 45 (1): 101-105. 10.1111/j.1600-079X.2008.00561.x.
CAS
Article
PubMed
Google Scholar
Wakatsuki A, Okatani Y, Ikenoue N, Izumiya C, Kaneda C: Melatonin inhibits oxidative modification of low‒density lipoprotein particles in normolipidemic post‒menopausal women. J Pineal Res. 2000, 28 (3): 136-142.
CAS
Article
PubMed
Google Scholar
Wakatsuki A, Okatani Y, Ikenoue N, Kaneda C, Fukaya T: Effects of short-term melatonin administration on lipoprotein metabolism in normolipidemic postmenopausal women. Maturitas. 2001, 38 (2): 171-177. 10.1016/S0378-5122(00)00221-8.
CAS
Article
PubMed
Google Scholar
Pawlikowski M, Kolomecka M, Wojtczak A, Karasek M: Effects of six months melatonin treatment on sleep quality and serum concentrations of estradiol, cortisol, dehydroepiandrosterone sulfate, and somatomedin C in elderly women. Neuroendocrinol Lett. 2002, 23: 17-
CAS
PubMed
Google Scholar
Rindone JP, Achacoso R: Effect of melatonin on serum lipids in patients with hypercholesterolemia: a pilot study. Am J Ther. 1997, 4 (11–12): 409-412.
CAS
Article
PubMed
Google Scholar
Cagnacci A, Arangino S, Renzi A, Paoletti AM, Melis GB, Cagnacci P, Volpe A: Influence of melatonin administration on glucose tolerance and insulin sensitivity of postmenopausal women. Clin Endocrinol. 2001, 54 (3): 339-346. 10.1046/j.1365-2265.2001.01232.x.
CAS
Article
Google Scholar
Grossman E, Laudon M, Zisapel N: Effect of melatonin on nocturnal blood pressure: meta-analysis of randomized controlled trials. Vasc Health Risk Manag. 2011, 7: 577-
PubMed Central
CAS
PubMed
Google Scholar
Lieu SJ, Curhan GC, Schernhammer ES, Forman JP: Rotating night shift work and disparate hypertension risk in African–Americans. J Hypertens. 2012, 30 (1): 61-66. 10.1097/HJH.0b013e32834e1ea3.
CAS
Article
PubMed
Google Scholar
Jehn ML, Brotman DJ, Appel LJ: Racial differences in diurnal blood pressure and heart rate patterns: results from the Dietary Approaches to Stop Hypertension (DASH) trial. Arch Internal Med. 2008, 168 (9): 996-10.1001/archinte.168.9.996.
Article
Google Scholar
Profant J, Dimsdale JE: Race and diurnal blood pressure patterns: a review and meta-analysis. Hypertension. 1999, 33 (5): 1099-1104. 10.1161/01.HYP.33.5.1099.
CAS
Article
PubMed
Google Scholar